News Releases
November 24, 2009
Prodesse's ProParaflu+(TM) Assay Cleared for US Marketing by FDA
October 29, 2009
FDA Grants Emergency Use Authorization of the Prodesse Pro-Flu-ST(TM)
October 22, 2009
Gen-Probe Completes Acquisition of Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases
October 6, 2009
Gen-Probe to Acquire Prodesse
September 23, 2009
Prodesse Acquires Non-Exclusive US Distribution Rights to Cepheid SmartCycler System
August 24, 2009
Prodesse Receives Special 510(k) for ProFlu+ Assay
July 1, 2009
Prodesse Announces Licensure of Two Additional Patents
May 13, 2009
Kevin Conroy, Former Third Wave CEO, Joins Prodesse Board
May 4, 2009
ProFlu+™ Detects Swine Flu
April 28, 2009
Prodesse Statement on ProFlu+™ and Swine Flu
April 16, 2009
FDA Clears Prodesse’s ProGastro Cd™ Assay for Clostridium difficile
April 14, 2009
Prodesse Submits ProParaflu+™ to FDA for 510(k) Clearance
February 3, 2009
Prodesse Submits ProGastro™ Cd (for Clostridium difficile) to FDA for 510(k) Clearance
November 12, 2008
Prodesse’s RT- PCR Pro hMPV+™ Assay Receives FDA Clearance
September 17, 2008
Prodesse Submits Pro hMPV+™ Assay to FDA for 510(k) Clearance
September 3, 2008
Prodesse Releases CE Marked Multiplex PCR Assay in Europe for Detection of Parainfluenza Virus
June 17, 2008
Prodesse Releases CE Marked PCR Assay in Europe for Detection of Human Metapneumovirus
June 4, 2008
Prodesse Begins Clinical Trials for ProParaflu+™
May 15, 2008
Prodesse Releases CE Marked PCR Assay in Europe for Detection of Toxigenic Clostridium difficile
May 5, 2008
Prodesse’s ProFlu+™ Assay Gains Special 510(k) Clearance Modifications
May 1, 2008
Prodesse Announces Clinical Trial Sites for ProGastro™ Cd
January 4, 2008
Prodesse’s Multiplex RT- PCR ProFlu+™ Assay Receives FDA Clearance
As Reported By: Washington Post
November 6, 2007
Prodesse Begins Clinical Trials for Pro hMPV+™ at Four US Laboratories
October 10, 2007
Prodesse Releases CE Marked ProFlu+™ Assay in Europe
August 14, 2007
Prodesse Licenses Anti-Primer technology developed at Dana-Farber Cancer Institute
July 31, 2007
Ira Marks, Diagnostics Industry Veteran, Joins Prodesse Board
June 21, 2007
Prodesse to Discontinue 3 Multiplex ASR’s from Sale in US
April 19, 2007
Prodesse to Host Panel Discussion at Clinical Virology Symposium
February 12, 2007
Prodesse Begins Clinical Trial for ProFlu+
August 9, 2006
Columbia University Medical Center, NewYork-Presbyterian Medical Center and Kaiser Permanente to Use Prodesse Reagents
July 21, 2006
Prodesse and Invitrogen Collaborate on First Molecular Diagnostic LUX™ Products
June 30, 2006
Prodesse Announces Licensing Agreeement with Roche
March 13, 2006
LabCorp® to Use Prodesse Reagents
March 8, 2006
Prodesse announces release of reagents for detection of newly discovered human metapneumovirus
March 6, 2006
Cleveland Clinic Health System to Use Prodesse Reagents
February 27, 2006
Prodesse Receives Biosearch Technologies, Inc. License
December 8, 2005
Prodesse to supply Lahey Clinic with ProFlu-1™ Reagents
September 19, 2005
Katherine Webster, President of Biotage, Biosystems Group, Joins Prodesse Board
August 23, 2005
Prodesse Releases Next Generation Real Time Multiplex PCR Reagents
August 23, 2005
Prodesse Receives Additional Convertible Debt Funding
July 12, 2005
Prodesse releases ProPneumo-1™ Reagents
June 21, 2005
Frank Langley, Former CEO of Pel-Freez Clinical Systems, Joins Prodesse Board
June 20, 2005
Prodesse's Hexaplex® Selected for Use in Phase 3 Clinical Trial
April 26, 2005
ProFlu-1™ Abstract Selected by ASM for Poster at 105th Annual Meeting
March 25, 2005
Bioterrorism Multiplex Assay Presented at ASM Biodefense Research Meeting
February 2, 2005
Steven Visuri, Prodesse CSO, to Speak at 2005 International Symposium on Respiratory Viral Infections
December 7, 2004
Prodesse Awarded ISO 13485 Certification
November 23, 2004
Prodesse, Inc. Appoints David J. Tyler VP, Manufacturing